Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 60.77 USD 0.75% Market Closed
Market Cap: 7.4B USD

Wall Street
Price Targets

CYTK Price Targets Summary
Cytokinetics Inc

Wall Street analysts forecast CYTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYTK is 81.15 USD with a low forecast of 55.55 USD and a high forecast of 126 USD.

Lowest
Price Target
55.55 USD
9% Downside
Average
Price Target
81.15 USD
34% Upside
Highest
Price Target
126 USD
107% Upside
Cytokinetics Inc Competitors:
Price Targets
DTIL
Precision BioSciences Inc
574% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
30% Upside
IKT
Inhibikase Therapeutics Inc
368% Upside
CANTA
Cantargia AB
118% Upside
ELIC
Elicera Therapeutics AB
46% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
91% Upside
BIIB
Biogen Inc
5% Upside
GILD
Gilead Sciences Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Cytokinetics Inc

For the last 13 years the compound annual growth rate for Cytokinetics Inc's revenue is 12%. The projected CAGR for the next 3 years is 170%.

12%
Past Growth
170%
Estimated Growth
Estimates Accuracy
6%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Cytokinetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Cytokinetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYTK's stock price target?
Price Target
81.15 USD

According to Wall Street analysts, the average 1-year price target for CYTK is 81.15 USD with a low forecast of 55.55 USD and a high forecast of 126 USD.

What is Cytokinetics Inc's Revenue forecast?
Projected CAGR
170%

For the last 13 years the compound annual growth rate for Cytokinetics Inc's revenue is 12%. The projected CAGR for the next 3 years is 170%.

Back to Top